Chronic Hand Eczema Patient Registry for Drug Safety and Effectiveness

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, observational registry enrolling adults with moderate-to-severe chronic hand eczema who are starting an eligible medication. Data are collected from patients and their treating providers during routine visits using standardized forms. The goal is to study long-term real-world safety and effectiveness of standard treatments, describe the disease course, and inform decision-making for patients, clinicians, and regulators. The registry may address multiple research questions and support risk–benefit evaluations by manufacturers and regulators. Participation relies on electronic data capture and ongoing consent.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* To be eligible to participate in this registry, an individual must meet all of the following criteria:

  1. Diagnosed with moderate-to-severe CHE by a dermatologist or other qualified healthcare provider at the time of enrollment and initiating an eligible medication.
  2. Is at least 18 years of age or older and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted at the time of enrollment
  3. Is willing and able to consent to participation in the registry
  4. Is willing and able to complete registry-related forms electronically via personal devices.
  5. Is willing and able to provide the information (first name, last name, email address, language and primary time zone) required to create an account to allow you to complete registry forms via a personal device;
  6. Is willing and able to provide Personal Information (full legal name, sex, date of birth, home address zip or postal code and email address or phone number at a minimum) if required based on registry location and applicable laws and regulations.

Exclusion Criteria:

An individual who meets any of the following criteria will be excluded from participation in the registry:

1\) Is participating or planning to participate in a blinded clinical trial for a CHE drug

Where it's running

• CorEvitas, LLC
  Waltham, Massachusetts, United States Recruiting

Study contacts

• Study coordinator: Chronic Hand Eczema Registry Team
• Email: CHEregistry@thermofisher.com
• Phone: +1 508 408 5531

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Collecting samples from people with skin conditions and healthy volunteers

  This study is collecting samples from people with different skin conditions and healthy volunteers to see how their biology differs and learn more about these conditions.

  Recruiting Innovaderm Research Inc. · Montreal, Quebec · NCT05994976

• Characterizing chronic hand eczema and its impact on quality of life

  This study is trying to understand different types of chronic hand eczema and atopic dermatitis in adults to see how they affect daily life and what factors might make them worse.

  Recruiting Innovaderm Research Inc. · Montreal, Quebec · NCT05026554

• Exploring the immune profile of chronic hand eczema

  This study is trying to understand the immune system's response in adults with chronic hand eczema to help create better, personalized treatments.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome · NCT06884163

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.